Congress Delays Hemp Ban 29 Days as Standalone Fix Remains Stalled
Lawmakers attached a hemp reprieve to the September continuing resolution, but no standalone bill has advanced despite bipartisan support.

Stunning architectural shot of the US Capitol under a clear blue sky.
The Vote Breakdown and What It Delays
The September 3 continuing resolution passed with 61 Senate votes, pushing the hemp-derived cannabinoid enforcement deadline from September 3 to October 2. The extension covers products containing delta-8 THC, THCA, and other cannabinoids synthesized or extracted from hemp, which the DEA classified as controlled substances under an interim final rule published in July. Without the delay, distributors would've faced immediate federal enforcement starting today.
The 29-day window doesn't change the underlying rule. It postpones compliance deadlines for inventory disposal, labeling changes, and state-level coordination with federal agents. Retailers in states without their own hemp-THC bans—roughly 18 states as of August—gained less than a month to liquidate stock or pivot product lines.
Why Congress Chose a Funding Bill Over Standalone Legislation
At least three standalone hemp bills have been introduced in the 119th Congress. None cleared committee. The Hemp Access and Consumer Protection Act (H.R. 4287) attracted 42 cosponsors but stalled in the House Energy and Commerce Committee in June. A Senate companion bill, S. 1782, has 14 cosponsors and no markup scheduled.
Leadership in both chambers has declined to bring hemp legislation to the floor as a standalone measure, citing the broader Farm Bill impasse. That five-year reauthorization has been delayed since September 2025 over a dispute on SNAP funding levels, leaving hemp policy—and commodity subsidies, crop insurance, and conservation programs—in limbo. Attaching hemp delays to continuing resolutions has become the default tactic, used three times since May.
The Farm Bill Impasse and Its Collateral Damage
The Farm Bill stalemate centers on a $28 billion gap between House and Senate proposals for SNAP benefit increases, an issue unrelated to hemp or cannabis. House Agriculture Committee Chair Glenn Thompson has refused to advance a bill that raises SNAP spending above 2023 levels. Senate Agriculture Chair Debbie Stabenow has conditioned her support on restoring pandemic-era benefit expansions. Neither side has moved since July.
Hemp provisions in both the House and Senate draft bills would've redefined "hemp" to exclude cannabinoids produced through isomerization or synthetic conversion, effectively closing the delta-8 loophole while preserving naturally occurring THCA flower. But those drafts remain unvoted, and leadership has given no timeline for floor action. For context on the original 2018 loophole, see the CannIntel topic hub on the federal hemp loophole.
What Happens October 2 Without Another Extension
If Congress doesn't pass another delay before October 2, the DEA's interim final rule takes full effect, making possession, distribution, and sale of hemp-derived delta-8 THC and THCA products a federal controlled-substance violation. The rule doesn't create new criminal penalties—existing Schedule I penalties apply—but it authorizes DEA field offices to coordinate with state and local law enforcement on civil asset forfeiture and administrative actions.
States with their own hemp-THC bans—including New York, Colorado, and Minnesota—have already begun enforcement. States without such laws face a coordination gap: local prosecutors may decline to pursue cases the DEA flags, and the agency hasn't published enforcement priorities or safe-harbor guidance for compliant operators. The October 2 deadline also triggers a 60-day comment period on the interim rule, after which the DEA will issue a final rule.
The Political Math and What Comes Next
The 61-39 vote margin suggests bipartisan support for delaying enforcement, but not for a permanent legislative fix. Fourteen Republicans and 47 Democrats voted for the extension. That coalition has held across three continuing resolutions since May, but it hasn't translated into committee action on standalone bills.
September 30 is the next funding deadline. If Congress attaches another hemp delay to the October continuing resolution, the cycle repeats. If it doesn't, enforcement begins October 2. The third scenario—a standalone hemp bill clearing both chambers before September 30—has no procedural path unless Farm Bill negotiations collapse entirely and leadership decouples hemp from the broader package. We'll be watching three indicators: whether Thompson schedules a markup on H.R. 4287, whether Stabenow softens her SNAP position, and whether the DEA publishes enforcement guidance before October 2.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What does the September 3 vote delay?
The vote delays enforcement of the DEA's interim final rule classifying hemp-derived delta-8 THC and THCA as controlled substances. The new deadline is October 2, 2026, giving retailers and manufacturers 29 additional days before federal enforcement begins.
Why hasn't Congress passed a standalone hemp bill?
At least three standalone hemp bills have been introduced, but none have cleared committee. Leadership has declined to bring them to the floor, citing the broader Farm Bill impasse over SNAP funding levels. Attaching delays to continuing resolutions has become the default tactic.
What happens if Congress does not pass another extension by September 30?
If no new delay is enacted, the DEA's interim final rule takes full effect October 2. Possession, distribution, and sale of hemp-derived delta-8 and THCA products become federal controlled-substance violations, and the DEA can coordinate enforcement with state and local agencies.
How does the Farm Bill impasse affect hemp policy?
The Farm Bill has been delayed since September 2025 over a $28 billion gap in SNAP benefit proposals. Hemp provisions in both House and Senate drafts would close the delta-8 loophole, but those drafts remain unvoted. Until the SNAP dispute resolves, hemp legislation stays stuck.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Nevada County Approves Dispensary Selection Process for Two Towns
Supervisors approved a process for choosing cannabis dispensary operators in North San Juan and Soda Springs, but the county notice leaves key details unstated.

DEA Accepts New Report in Rescheduling Hearing; Foes Seek Discovery
DEA does not object to a new report entering the marijuana rescheduling record, while opponents ask for added testimony and document discovery.

Puerto Rico Rolls Back Medical Cannabis Workplace Protections
High Times Magazine reports Puerto Rico has narrowed employment protections for medical cannabis patients, raising questions about which workers lose coverage and which keep it.
More from the newsroom

Organigram enters fight for Aurora as Curaleaf bid clock runs
British American Tobacco's stake in Organigram could put the tobacco giant at the center of the Aurora contest before Curaleaf's offer expires Dec. 4.

L.A. Cannabis Industry Rallies Behind Nithya Raman, Substack Reports
A High Adam post says Los Angeles operators are energizing around Councilmember Nithya Raman, but the platform details behind the 'actual plan' remain unverified.

Tilray Medical Wins Approval for In-House EU-GMP Cannabis Testing
Tilray Medical can now run EU-GMP quality testing in-house, a move that could shift lab costs and batch-release timing, though key details remain undisclosed.